Vascular Biogenics Ltd (VBLT)

NASDAQ
1.770
+0.090(+5.36%)
After Hours
1.790
+0.020(+1.13%)
- Real-time Data
  • Volume:
    147,840
  • Day's Range:
    1.660 - 1.850
  • 52 wk Range:
    1.100 - 3.040

VBLT Overview

Prev. Close
1.68
Day's Range
1.66-1.85
Revenue
700K
Open
1.67
52 wk Range
1.1-3.04
EPS
-0.47
Volume
147,840
Market Cap
122.73M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
160,714
P/E Ratio
-
Beta
1.05
1-Year Change
-24.36%
Shares Outstanding
69,337,312
Next Earnings Date
Aug 15, 2022
What is your sentiment on Vascular Biogenics?
or
Market is currently closed. Voting is open during market hours.

Vascular Biogenics Ltd News

Vascular Biogenics Ltd Analysis

Vascular Biogenics Ltd Company Profile

Vascular Biogenics Ltd Company Profile

Employees
38

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company’s lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi’in, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong BuySell
Technical IndicatorsStrong SellNeutralStrong BuyStrong BuyStrong Sell
SummaryNeutralBuyStrong BuyStrong BuyStrong Sell
  • waiting good news definitely!👍
    0
    • good job!, congratulations!
      0
      • the Big Risk in Life is not to lose some money , Big Risk It is not investigate and not try to be better..
        0
        • big opportunity if buy and hold..besides science interesting
          0
          • we trust in projects of this company, really amazing ..
            0
            • waiting news about this beautiful company and investing a lot...hold and up!
              0
              • sorry actually day after tomorrow
                0
                • phase 3 report tomorrow
                  0
                  • new to this stock what's going on with it
                    0
                    • new to this stock what's going on with it
                      0